CME Working Capital vs Weighted Average Shares Analysis
CME Stock | USD 208.46 5.15 2.41% |
Trend analysis of CME Group balance sheet accounts such as Short Long Term Debt Total of 2.4 B, Other Current Liabilities of 98 B or Total Current Liabilities of 98.1 B provides information on CME's total assets, liabilities, and equity, which is the actual value of CME Group to its prevalent stockholders. By breaking down trends over time using CME balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
CME |
About CME Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of CME Group at a specified time, usually calculated after every quarter, six months, or one year. CME Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of CME and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which CME currently owns. An asset can also be divided into two categories, current and non-current.
CME Balance Sheet Chart
CME Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how CME Group uses and utilizes its capital. It also shows what exactly a company owns and owes.
At present, CME's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 98.1 B, whereas Total Stockholder Equity is forecasted to decline to about 17.6 B. Add Fundamental
Total Assets
Total assets refers to the total amount of CME assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in CME Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on CME balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of CME Group are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most indicators from CME's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into CME Group current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. At present, CME's Enterprise Value is projected to increase significantly based on the last few years of reporting.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 3.9B | 4.3B | 4.5B | 2.5B | Total Revenue | 4.7B | 5.0B | 5.6B | 3.0B |
CME fundamental ratios Correlations
Click cells to compare fundamentals
CME Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CME fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 75.2B | 124.7B | 196.8B | 174.2B | 129.8B | 136.3B | |
Short Long Term Debt Total | 3.7B | 3.4B | 3.4B | 3.4B | 3.9B | 2.4B | |
Other Current Liab | 38.5B | 88.1B | 159.6B | 132.2B | 93.3B | 98.0B | |
Total Current Liabilities | 38.5B | 88.2B | 160.4B | 137.7B | 93.4B | 98.1B | |
Total Stockholder Equity | 26.1B | 26.3B | 27.4B | 26.9B | 26.7B | 17.6B | |
Other Liab | 6.2B | 6.7B | 6.3B | 5.7B | 6.6B | 6.2B | |
Property Plant And Equipment Net | 544M | 579.2M | 505.3M | 455.5M | 681.5M | 483.4M | |
Net Debt | 2.2B | 1.8B | 610.2M | 718.3M | 966.7M | 843.5M | |
Retained Earnings | 5.0B | 5.0B | 5.2B | 4.7B | 4.5B | 3.0B | |
Accounts Payable | 61.9M | 69.3M | 48.8M | 121.4M | 90.6M | 51.7M | |
Cash | 1.6B | 1.6B | 2.8B | 2.7B | 2.9B | 3.1B | |
Non Current Assets Total | 35.6B | 35.4B | 35.0B | 35.1B | 34.8B | 24.0B | |
Non Currrent Assets Other | 2.1B | 2.0B | 3.3B | (3.1B) | 514.1M | 1.0B | |
Other Assets | 545.9M | 7.3B | 3.3B | 574M | 134.4M | 127.7M | |
Long Term Debt | 3.7B | 3.4B | 2.7B | 3.4B | 3.4B | 2.5B | |
Cash And Short Term Investments | 1.6B | 1.7B | 2.9B | 2.8B | 3.0B | 2.7B | |
Net Receivables | 491.8M | 461.3M | 434.5M | 483.2M | 1.3B | 1.3B | |
Common Stock Shares Outstanding | 358.2M | 358.5M | 358.9M | 359.2M | 359.5M | 311.9M | |
Liabilities And Stockholders Equity | 75.2B | 124.7B | 196.8B | 174.2B | 129.8B | 136.3B | |
Non Current Liabilities Total | 10.5B | 10.1B | 9.0B | 9.6B | 9.6B | 7.4B | |
Other Current Assets | 360.1M | 302M | 423M | 524.9M | (4.3B) | (4.1B) | |
Other Stockholder Equity | 21.1B | 21.2B | 22.2B | 22.3B | 22.3B | 14.5B | |
Total Liab | 49.1B | 98.3B | 169.4B | 147.3B | 103.1B | 108.3B | |
Property Plant And Equipment Gross | 544M | 579.2M | 505.3M | 455.5M | 1.3B | 1.4B | |
Total Current Assets | 39.6B | 89.3B | 161.8B | 139.1B | 94.9B | 99.6B | |
Accumulated Other Comprehensive Income | 3.4M | 134.9M | 53.5M | (133.3M) | (55.6M) | (52.8M) | |
Property Plant Equipment | 544M | 579.2M | 505.3M | 837.6M | 963.2M | 490.1M | |
Short Term Investments | 83.2M | 100.9M | 115M | 96M | 111.7M | 106.1M | |
Inventory | 37.1B | 86.8B | 158.0B | 135.3B | 155.5B | 163.3B | |
Short Term Debt | 49.7M | 52.2M | 749.4M | 16M | 55.1M | 52.3M | |
Intangible Assets | 22.3B | 22.0B | 20.7B | 20.4B | 20.2B | 18.4B | |
Good Will | 10.7B | 10.8B | 10.5B | 10.5B | 10.5B | 8.9B | |
Retained Earnings Total Equity | 4.9B | 5.0B | 5.0B | 5.2B | 5.9B | 3.7B | |
Deferred Long Term Liab | 5.7B | 5.6B | 5.6B | 5.4B | 6.2B | 4.7B | |
Net Tangible Assets | (6.9B) | (6.5B) | (3.8B) | (4.0B) | (4.7B) | (4.9B) | |
Long Term Debt Total | 3.8B | 3.7B | 3.4B | 2.7B | 3.1B | 2.9B |
Pair Trading with CME
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CME position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CME will appreciate offsetting losses from the drop in the long position's value.Moving together with CME Stock
0.63 | ICE | Intercontinental Exchange | PairCorr |
Moving against CME Stock
0.47 | FG | FG Annuities Life | PairCorr |
The ability to find closely correlated positions to CME could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CME when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CME - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CME Group to buy it.
The correlation of CME is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CME moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CME Group moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CME can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CME Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for CME Stock analysis
When running CME's price analysis, check to measure CME's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CME is operating at the current time. Most of CME's value examination focuses on studying past and present price action to predict the probability of CME's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CME's price. Additionally, you may evaluate how the addition of CME to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is CME's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CME. If investors know CME will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CME listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 4.45 | Earnings Share 8.78 | Revenue Per Share 15.638 | Quarterly Revenue Growth 0.032 |
The market value of CME Group is measured differently than its book value, which is the value of CME that is recorded on the company's balance sheet. Investors also form their own opinion of CME's value that differs from its market value or its book value, called intrinsic value, which is CME's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CME's market value can be influenced by many factors that don't directly affect CME's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CME's value and its price as these two are different measures arrived at by different means. Investors typically determine if CME is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CME's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.